Related Experiment Video
Updated: May 21, 2026

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Roux-en-Y gastric bypass: Pilot study results from a resource constrained setting
A Khamajeet1, A Diab1, T Biesman-Simons1
1Division of General Surgery, Department of Surgery, New Somerset Hospital, University of Cape Town, South Africa.
Summary
Roux-en-Y gastric bypass (RYGB) is effective for weight loss and comorbidity resolution in South Africa's low-resource settings. This pilot study shows significant improvements in obesity-related conditions over three years.
Area of Science:
- Bariatric Surgery
- Public Health
- Metabolic Disorders
Background:
- Obesity is a global health crisis with severe consequences.
- Metabolic and bariatric surgery (MBS) offers sustained weight loss and improved comorbidities.
- MBS accessibility is limited in South Africa's public sector due to high costs.
Purpose of the Study:
- To assess the outcomes of Roux-en-Y gastric bypass (RYGB) in a resource-constrained South African setting.
- To evaluate weight loss, comorbidity resolution, and complication rates over a 3-year period.
- To determine the feasibility of MBS in a low-resource public healthcare environment.
Main Methods:
- Retrospective analysis of 17 patients undergoing RYGB.
- Data collected from August 2017 to February 2020 at New Somerset Hospital, South Africa.
- Primary outcomes: percentage total weight loss (%TWL), excess weight loss (%EWL), excess BMI loss (%EBMIL). Secondary outcomes: comorbidity resolution (T2D, hypertension, GERD, dyslipidemia).
Main Results:
- Mean BMI reduced from 48.3 to 38.35 kg/m² at 3 years.
- Significant weight loss achieved: %TWL 20.3%, %EWL 42.5%, %EBMIL 43.2%.
- Comorbidity resolution rates: 50% for type 2 diabetes, 71.4% for GERD, 66.7% for dyslipidemia. Low complication rate (one port site hernia).
Conclusions:
- MBS is feasible and effective in resource-constrained settings like South Africa.
- RYGB shows significant potential for managing the obesity epidemic and its comorbidities.
- Further research with larger cohorts and longer follow-up is recommended to validate findings.

